Keeping up with health and wellness news from Comoros

Provided by AGP

Healthcare Brief Comoros
Got News to Share?
Got News to Share? Explore more publications!

Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 6, 2026

Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update
May. 6, 2026

Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference
May. 6, 2026

Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference

Indeterminate GlobeNewswire
Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement
May. 6, 2026

Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement

Indeterminate GlobeNewswire
UroGen Reports ZUSDURI™ Revenue More Than Doubled Quarter-over-Quarter and Provides First Quarter 2026 Financial Results and Highlights
May. 6, 2026

UroGen Reports ZUSDURI™ Revenue More Than Doubled Quarter-over-Quarter and Provides First Quarter 2026 Financial Results and Highlights

Indeterminate GlobeNewswire
PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results
May. 6, 2026

PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results

Indeterminate GlobeNewswire
CRYSVITA® Now Publicly Reimbursed for the Treatment of Adults with XLH in Four Provinces and Federal Non-Insured Health Benefits Program
May. 6, 2026

CRYSVITA® Now Publicly Reimbursed for the Treatment of Adults with XLH in Four Provinces and Federal Non-Insured Health Benefits Program

Indeterminate GlobeNewswire
CRYSVITA(MC) est désormais remboursé par les régimes publics pour le traitement des adultes atteints d’XLH dans quatre provinces et dans le cadre du Programme fédéral des services de santé non assurés
May. 6, 2026

CRYSVITA(MC) est désormais remboursé par les régimes publics pour le traitement des adultes atteints d’XLH dans quatre provinces et dans le cadre du Programme fédéral des services de santé non assurés

Indeterminate GlobeNewswire
Erasca to Present at the Bank of America Securities Health Care Conference
May. 6, 2026

Erasca to Present at the Bank of America Securities Health Care Conference

Indeterminate GlobeNewswire
Brain Cancer Canada Awards $75,000 to Groundbreaking Pediatric Brain Cancer Study at University of Manitoba Targeting Hard-to-Treat DMG-P Tumours
May. 6, 2026

Brain Cancer Canada Awards $75,000 to Groundbreaking Pediatric Brain Cancer Study at University of Manitoba Targeting Hard-to-Treat DMG-P Tumours

Indeterminate GlobeNewswire
PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026
May. 6, 2026

PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026

Indeterminate GlobeNewswire
Kura Oncology to Participate in Bank of America Securities Healthcare Conference
May. 6, 2026

Kura Oncology to Participate in Bank of America Securities Healthcare Conference

Indeterminate GlobeNewswire
BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil
May. 6, 2026

BEYONTTRA™ (acoramidis), the First Near-Complete TTR Stabilizer (≥90%), Approved by ANVISA to Treat ATTR-CM in Brazil

Indeterminate GlobeNewswire
Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response
May. 6, 2026

Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response

Indeterminate GlobeNewswire
Cronos Expands Pre-Roll Portfolio with Spinach STIX®
May. 6, 2026

Cronos Expands Pre-Roll Portfolio with Spinach STIX®

Indeterminate GlobeNewswire
Bioventus Reports First Quarter Financial Results
May. 6, 2026

Bioventus Reports First Quarter Financial Results

Indeterminate GlobeNewswire
Medline Reports First Quarter 2026 Results
May. 6, 2026

Medline Reports First Quarter 2026 Results

Indeterminate GlobeNewswire
Immusoft to Present Data Highlighting Positive Results from the World’s First Engineered B Cell in a Human Clinical Trial at ASGCT 2026
May. 6, 2026

Immusoft to Present Data Highlighting Positive Results from the World’s First Engineered B Cell in a Human Clinical Trial at ASGCT 2026

Indeterminate GlobeNewswire
Altimmune to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026
May. 6, 2026

Altimmune to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026

Indeterminate GlobeNewswire
BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer
May. 6, 2026

BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer

Indeterminate GlobeNewswire
Crescent Biopharma to Present at May Investor Conferences
May. 6, 2026

Crescent Biopharma to Present at May Investor Conferences

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn

Sign up for:

Healthcare Brief Comoros

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.